Volume 19, Issue 1
مرور بر اساس
ارسال های اخیر
-
Body outlining using Tc-99m filled flood source for lymphoscintigraphy imaging
(Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 2011-12-01)Introduction: In the current study, we evaluated the feasibility of body outlining using Tc-99m filled flood source for lymphoscintigraphy imaging. Methods: 80 patients were included in the study. Sentinel node mapping ...
-
Production of Holmium-166 DOTMP: A promising agent for bone marrow ablation in hematologic malignancies
(Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 2011-12-01)Intoduction: Therapeutic radiopharmaceuticals are radiolabeled molecules to deliver sufficient doses of ionizing radiation to specific disease sites such as bone metastases, brain and liver tumors and bone marrows malignancies ...
-
Preparation and evaluation of 67Ga-DOTA-Bombesin (7-14) as a tumor scintigraphic agent
(Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 2011-12-01)Introduction: Bombesin is a 14-aminoacid peptide isolated from frog skin. The mammalian counterparts of the frog peptide are neuromedin B (NMB) and gastrin-releasing peptide (GRP). Bombesin (BBN) is a peptide showing high ...
-
Additive clinical value of bone scintigraphy in patients with malignant tumors with absence of localized bone pain: A report on most common sex-related cancers
(Research Center for Nuclear Medicine (Tehran University of Medical Sciences), 2011-12-01)Introduction: Almost all malignant tumors have the potential to eventually produce bone metastasis. The aim of the current study was to report the distribution pattern and imaging characteristics of bone metastases detected ...
